State Street's crypto push, FDA delays review of Eli Lilly GLP-1 | | StockXpo

Try Stockxpo Premium

State Street’s crypto push, FDA delays review of Eli Lilly GLP-1

Published: Thursday, January 15, 2026 · 7:09 PM  |  Updated: Thursday, January 15, 2026 · 7:09 PM

📊 136 views

SHARE











00:01 Speaker A

It’s time for Yahoo Finance’s Market Minute.

00:04 Speaker A

US stocks trying to recover from a second straight day of losses here.

00:07 Speaker A

TSMC’s strong outlook boosting AI hopes and lifting chip stocks in today’s trade.

00:12 Speaker A

Bank stocks meanwhile also rallying. It’s after upbeat earnings reports from Goldman Sachs and Morgan Stanley.

00:18 Speaker A

And next up, State Street, the financial Services giant is readying a collection of cryptocurrency and tokenized products for its clients.

00:24 Speaker A

That’s according to Bloomberg. The bank will shortly begin offering money market ETF and cash products, including tokenized deposits and stable coins.

00:33 Speaker A

And shares of healthcare stocks under pressure as the FDA reportedly delays reviews of several drugs in Trump’s fast track program.

00:41 Speaker A

That’s according to Reuters, US Food and Drug Administration pushing back reviews of Sanofi’s diabetes treatment and Disc Medicine’s experimental drug.

00:49 Speaker A

Eli Lilly’s weight loss pill also being hit with FDA delays.

00:52 Speaker A

And that’s your Yahoo Finance market minute. Scan the QR code below to track the best and worst performing stocks for the trading session.

Source

MORE IN INSIDE CRYPTO

scroll to top